These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Therapeutic strategies involving antimicrobial treatment of small animals with peritonitis. Thornhill JA. J Am Vet Med Assoc; 1984 Nov 15; 185(10):1181-4. PubMed ID: 6392252 [No Abstract] [Full Text] [Related]
4. Pharmacokinetic aspects during continuous ambulatory peritoneal dialysis: a literature review. Janknegt R, Koks CH. Pharm Weekbl Sci; 1984 Dec 14; 6(6):229-36. PubMed ID: 6393041 [Abstract] [Full Text] [Related]
5. Intraperitoneal teicoplanin in the treatment of peritonitis associated with continuous ambulatory peritoneal dialysis. Bowley JA, Pickering SJ, Scantlebury AJ, Ackrill P, Jones DM. J Antimicrob Chemother; 1988 Jan 14; 21 Suppl A():133-9. PubMed ID: 2965125 [Abstract] [Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of antistaphylococcal antibiotics in continuous ambulatory peritoneal dialysis patients. Keller E. Perit Dial Int; 1993 Jan 14; 13 Suppl 2():S367-70. PubMed ID: 8399613 [Abstract] [Full Text] [Related]
7. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis. Mars RL, Moles K, Pope K, Hargrove P. Adv Perit Dial; 2000 Jan 14; 16():280-4. PubMed ID: 11045311 [Abstract] [Full Text] [Related]
15. Efficacy and safety of meropenem plus tobramycin followed by meropenem plus vancomycin for treating peritonitis in patients on continuous ambulatory peritoneal dialysis. Kobayashi K, Nakamoto H, Okada S, Hoshitani K, Uchida K, Arima H, Shoda J, Takane Y, Ikeda N, Sugahara S, Okada H, Suzuki H. Adv Perit Dial; 2006 Nov 14; 22():65-8. PubMed ID: 16983942 [Abstract] [Full Text] [Related]